Latest reporting
HHS Says Opioid Deaths Are at a Decade Low. The Number It Led With Isn't an Opioid Number.
HHS says opioid deaths are at their lowest in nearly a decade, but the headline figure is an all-cause death rate. Minnesota's new data shows where the deaths are moving.
Nobody Can Say Why You Stopped Dying. Until They Can, Don't Bet on It Lasting.
A JAMA analysis of 2.5 million EMS overdose responses finds naloxone use did not rise as deaths fell. The likeliest cause, a weaker fentanyl supply, can reverse. Here is what that means this week.
Overdose Deaths Fell 12.3%. The Numbers Came From the Same Office That Wants Credit.
CDC provisional data show 67,798 overdose deaths in the 12 months ending March 2026, down 12.3%. HHS officials claim credit as a SAMHSA nominee awaits confirmation.
Through eight lenses
Science
Opioids bind to μ, δ, and κ receptors in the central and peripheral nervous system. Agonists (morphine, heroin, fentanyl) produce analgesia, euphoria, and respiratory depression; partial agonists (buprenorphine) and antagonists (naloxone, naltrexone) occupy receptors differently. Fentanyl's potency (~50–100× morphine) reflects receptor affinity, not a different mechanism — which is why overdose reversal still works, just often requiring higher or repeated naloxone doses.
Biology
Acute effects: respiratory depression (the killer), miosis, GI slowdown, analgesia. Chronic use downregulates endogenous opioid production, which is the neurobiology behind withdrawal — real, measurable, not "in someone's head." Long-term health impacts include endocrine suppression, constipation, cardiovascular stress, and (with injection) endocarditis and soft-tissue infections. Fentanyl's pharmacokinetics (rapid onset, short half-life in plasma but redistribution into tissue) explain its overdose profile.
Psychology
Opioid use disorder has the highest bio-genetic contribution of any SUD in twin studies (~50–60% heritability). The "warm blanket" subjective experience — which people in active use describe consistently — reflects μ-receptor activation in regions governing social pain. That's why opioids map so cleanly onto trauma, loneliness, and chronic pain.
Policy
Schedule II (except buprenorphine at III, heroin at I). DEA quota system governs legitimate supply. The 2023 X-Waiver elimination removed the barrier to buprenorphine prescribing — any provider with a Schedule III DEA number can now prescribe. [Telehealth prescribing is extended through 2026](/newsroom/dea-extends-telemedicine-buprenorphine-2026) with permanent 6-month flexibility for buprenorphine.
Trends
CDC provisional data shows ~72,000 overdose deaths in the 12 months ending October 2025, a 17% decline from the 2023 peak of ~107,000. Synthetic opioids (fentanyl + analogs) remain in 69–75% of these deaths. Emerging: nitazenes (more potent than fentanyl, naloxone-reversible but may require higher doses) and xylazine (not an opioid, but in the supply — see [SP-15](/newsroom/xylazine-what-it-is-why-it-matters)).
HHS Says Opioid Deaths Are at a Decade Low. The Number It Led With Isn't an Opioid Number.
Oct 31Overdose Deaths Fell 12.3%. The Numbers Came From the Same Office That Wants Credit.
Oct 22Arizona Is Suing the Opioid Middlemen. Its Own Prisons Spent $50.9 Million of the Last Settlement on Something Else.
Oct 21
Treatment
[MAT](/newsroom/mat-explained-2026) is the evidence-based standard: buprenorphine, methadone, and extended-release naltrexone all reduce mortality by ~50% vs. non-medication treatment in meta-analyses. Counseling helps but is not required to start MAT. Residential programs, IOP, peer recovery coaching, and 12-step all have roles, but without MAT the evidence for OUD treatment alone is weak.
Patients in Franklin County Used to Drive an Hour for Methadone. A Settlement Grant Just Ended That.
Oct 17CVS Pays $315 Million and Admits Nothing. The Pharmacist at the Counter Pays Too.
Oct 16Eight Communities Get $12 Million Each to Pair Street Outreach With Housing. Everyone Else Gets the Press Release.
Oct 8
Harm Reduction
Naloxone saves lives and is now available OTC (Narcan) in most states. Fentanyl test strips, safer-use education, Good Samaritan protections, syringe service programs, and (in some jurisdictions) overdose prevention centers. Harm reduction is not antithetical to recovery — SAMHSA's 2022 harm reduction pillar makes this explicit.